arrow&v

Continuum of Care for Hodgkin Lymphoma: Impact of Modern Therapy on Postacute Morbidity and Mortality

Evens AM, Parsons SK.

2020-12

Longitudinal Assessment of Health-Related Quality of Life Among Survivors of Hodgkin Lymphoma: It Is About Time!

Parsons SK.

2020-09

First-line Treatment in Older Patients With Hodgkin Lymphoma: A Surveillance, Epidemiology, and End Results (SEER)-Medicare Population-Based Study.

Rodday AM, Hahn T, Kumar AJ, Lindenauer PK, Friedberg JW, Evens AM, Parsons SK.

2020-02

Closing the survivorship gap in children and adolescents with Hodgkin lymphoma.

Castellino SM, Parsons SK, Kelly KM.

2019-12

Assessing the risk of cardiac toxicity after contemporary treatment for Hodgkin lymphoma: a systematic review.

Fu J, Upshaw J, Cohen J, Rodday AM, Saunders T, Kelly M, Evens AM, Parsons SK.

2018-08

Early-stage hodgkin lymphoma in the modern era: simulation modeling to delineate long-term patient outcomes.

Parsons SK, Kelly MJ, Cohen JT, Catellino SM, Henderson TO, Kelly KM, Keller FG, Henzer TJ, Kumar AJ, Johnson P, Meyer RM, Radford J, Raemaekers J, Hodgson DC, Evens AM.

2018-07

Outcomes in adolescents and young adults with Hodgkin lymphoma treated on US cooperative group protocols: An adult intergroup (E2496) and Children's Oncology Group (COG AHOD0031) comparative analysis.

Henderson TO, Parsons SK, Wroblewski KE, Chen L, Hong F, Smith SM, McNeer JL, Advani RH, Gascoyne RD, Constine LS, Horning S, Bartlett NL, Shah B, Connors JM, Leonard JI, Kahl BS, Kelly KM, Schwartz CL, Li H, Friedberg JW, Friedman DL, Gordon LI, Evens AM

2018-01

Health-related quality of life in Hodgkin lymphoma: a systematic review.

Linendoll N, Saunders T, Burns R, Nyce JD, Wendell KB, Evens AM, Parsons SK

2016-07